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820 The Journal of Thoracic and CardioIam glad to have the opportunity to comment on the article by Rogers andcolleagues,1 which contains an excellent discussion of both the potentialbenefits and hazards of using formal statistical monitoring procedures forclinical data. I particularly welcome the manner in which the authors warnabout the possible misinterpretations of the graphs and their recommenda-tion to view multiple complementary charts.
It would be easy to scoff at the growing enthusiasm and spirit of discovery
concerning such monitoring procedures, given that Shewhart control charts were
being recommended in an industrial context more than 70 years ago,2 and sequential
probability ratio tests (SPRT) were developed independently by Wald3 in the United
States and Barnard4 in the United Kingdom in the early 1940s. But the recent
industrial cumulative sum (CUSUM) literature, for example Hawkins and Olwell,5
shows that many research issues of crucial importance appear to be outstanding, for
example, risk adjustment, allowance for overdispersion, multiple systems, and so
on. Increased demands for quality assurance in complex medical systems are fueling
strong interest in good methodology,6 and previously exotic phrases such as “risk-
adjusted CUSUMs” are becoming standard language. This is a particularly exciting
period in collaborative research.
My comments concern seven main aspects that need to be considered when
designing any monitoring system and focus on what I believe to be currently
important issues. The term system is used to imply a process that involves more
than, say, a single surgeon analyzing results of a single procedure; rather, it involves
some monitoring body given responsibility for quality assurance of a number of
different outcomes.
1. Unit being monitored. Traditionally, discussion of statistical process control
methods has focused on a single “unit” being monitored, whether an industrial
process or a surgeon. But an organization charged with quality assurance may
be monitoring many such units, and the properties of any system need to be
evaluated accordingly. This multiplicity issue may lead one to consider a
composite model of all the units, for example, a hierarchical model leading to
“shrunk estimates,”7 or an alternative to standard type I error rates, such as
estimation of false discovery rates,8 essentially the predictive value of a
positive signal.
2. Event being monitored. Again, the traditional focus has been on a single series,
whereas in practice a health care system is likely to be monitoring many,
perhaps hundreds, of indicators. Some selection of indicators, or amalgam-
ation into composites, may be possible, but this additional source of multi-
plicity also needs to be investigated when characterizing the properties of any
system.
3. Risk adjustment of outcomes. Rogers and colleagues1 state the importance of
risk adjustment, but also recognize that it is always inadequate. One response
is to be more flexible in the “target” performance by allowing a certain degree
of variability due to the effects of many small, unobserved risk factors. This
leads naturally to allowance for overdispersion.9
4. Choice of summary statistic for monitoring. As Rogers and colleagues1 em-
phasize, it is inappropriate to try to select a single summary statistic to
monitor. Different choices have different strengths in terms of interpretability
and statistical properties. For example, Figure 1 shows the experience of serial
murderer Dr Harold Shipman (data provided by Baker10 and previously
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limits have been adjusted for the overdispersion factor
found by Aylin and colleagues.9 By plotting both the
observed and expected deaths (top left), we can see
that some of the excess in later years resulted from a
decline in expected deaths (in part because Dr Ship-
man had already murdered a substantial proportion of
his older patients). The Shewhart chart (top right)
shows when individual years were out of control, the
cumulative excess mortality chart (bottom left, also
known as VLAD or CRAM), is easy to interpret,
although the risk-adjusted CUSUM (RA-CUSUM;
bottom right) formally provides a most powerful test.
There seems no reason to select a single chart to
display; the RA-CUSUM may be used as a formal
trigger of an alarm, but the other plots aid in interpre-
tation. My personal preference is now for the RA-
CUSUM12 rather than the SPRT. As Rogers and col-
leagues1 point out, the RA-CUSUM has the same
steps as the SPRT, but is constrained to lie above 0.
Figure 1. Sequential monitoring of death certificates
expected number of deaths, with expected number
Cumulative observed minus expected deaths (cumula
dardized excess deaths. Shewhart chart limits (dot-da
excess mortality. (Note: Control limits have been ad
inadequate risk adjustment, per Aylin and colleagues
(RA-CUSUM). RA-CUSUM is based on log-likelihood ra
theory, this procedure might have detected excess mor
on to kill at least 150 more people. In practice, howeve
would have been impossible, because no linkage betwThis means that it cannot build up credit and so retains
The Journal of Thoracisensitivity, but formally has type I error of 1 and type
II error of 0, because it is guaranteed to eventually
reject the null.13
5. Role of discounting past experience. It seems reason-
able to discount past experience to some extent, be-
cause this leads to an attractive emphasis on current
performance and so avoids having to specify a fixed
start time for the monitoring process. Discounted
methods lead naturally to use of exponentially
weighted moving average (EWMA) estimates, as used
by de Leval and associates,14 which are fine as se-
quential estimates. It would seem natural to investi-
gate developments such as risk-adjusted EWMAs and
exponentially weighted RA-CUSUMs.
6. Selection of thresholds for action. Rogers and col-
leagues1 set their thresholds on the attractive and
familiar basis of type I and type II error rates. How-
ever, this is not appropriate for risk-adjusted RA-
CUSUMs, and the numerous allowances for multiplic-
ity described previously also play havoc with any
ned by Dr Harold Shipman. Top left: Observed and
ed on experience of local colleagues. Bottom left:
xcess mortality). Top right: Shewhart charts of stan-
t lines) are based on 3 SE difference in standardized
d for overdispersion multiplier of 3.42 to allow for
ttom right: Log-likelihood ratio risk-adjusted CUSUM
ability to detect doubling of risk (dot-dash-dot line). In
in Shipman’s experience in 1984, after which he went
cility for monitoring mortality of a general practitioner
records was made.sig
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potential thresholds in terms of their performance both
on simulated data and also on real past data. Aylin and
colleagues9 have adopted this approach for RA-
CUSUMs, reporting both sensitivity and false discov-
ery rates across a limited period.
7. Actions to be taken. Strictly speaking, it is impossible
to set thresholds unless one knows what actions are to
be taken in response to their being crossed, and hence
the design of a monitoring system must be intimately
driven by its context and intended use. Any response
should be in a prespecified and staged manner, with
the first step being to check the data carefully! It is
vital that these actions be considered at the design
stage to avoid a well-designed statistical monitoring
system becoming discredited through inappropriate
use.
I feel fortunate to be working in an area in which good
methodology, founded on strong traditional principles but
updated in response to modern demands, can be applied to
important problems. The article by Rogers and colleagues1
is a valuable contribution to this movement.
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